Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
about
Physiological and pathological implications of 5-hydroxymethylcytosine in diseasesHTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cellsMarine-derived chromopeptide A, a novel class I HDAC inhibitor, suppresses human prostate cancer cell proliferation and migration.A Flavone Constituent from Myoporum bontioides Induces M-Phase Cell Cycle Arrest of MCF-7 Breast Cancer Cells.HDACs and HDAC Inhibitors in Cancer Development and Therapy.Treatment approaches of hard-to-treat non-Hodgkin lymphomas.Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis.Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition.AP-1 confers resistance to anti-cancer therapy by activating XIAP.
P2860
Q26749375-EAAAE9FD-AA99-4778-8564-CD505534DB06Q37607905-CAA562F9-EB81-47A5-ABF8-B34CD7D1C5ADQ37744742-B2DE02D2-42DC-4957-AAC8-9FFDEBD02871Q38712222-759579B1-0487-4A26-AD8F-99C411639E43Q38947405-9B7C1B0B-6CD7-4050-A8CC-43C0C379E9F5Q39091822-5D804E82-7279-4FC3-B93C-2E2ADD4F839FQ39914674-6831EABD-1D66-4EDE-987B-7C99D2E1B9EBQ47130359-F19704EA-C511-4DC4-BE07-1DFB97879089Q51102354-9E6C3E11-5CC6-4A2A-9813-67924AC6DC63Q55110970-35051C82-8CA1-4A94-97F9-520AE389D39BQ55478598-4D8A1D9F-AA7D-419A-9CF9-4D29600C8BC1
P2860
Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Vorinostat, a histone deacetyl ...... cells to chemotherapy agents.
@en
type
label
Vorinostat, a histone deacetyl ...... cells to chemotherapy agents.
@en
prefLabel
Vorinostat, a histone deacetyl ...... cells to chemotherapy agents.
@en
P2093
P2860
P1476
Vorinostat, a histone deacetyl ...... cells to chemotherapy agents.
@en
P2093
Cory Mavis
Francisco J Hernandez-Ilizaliturri
Myron S Czuczman
Qunling Zhang
P2860
P2888
P304
P356
10.1007/S00432-015-2026-Y
P577
2015-08-28T00:00:00Z